Support global clinical research with accurate, consistent, and patient-appropriate translation across the clinical trial lifecycle—from protocols and informed consent forms to site documentation, clinical outcome assessments, safety communications, clinical reports, and digital trial content.
Sesen helps pharmaceutical and biotechnology sponsors, CROs, medical device companies, digital health organizations, and research teams coordinate multilingual clinical content across countries, languages, sites, and study phases. Professional native life sciences linguists work within controlled terminology, independent review, AI-assisted quality assurance, and final human quality control workflows designed for high-stakes clinical research.
Clinical trials generate an interconnected body of content that must remain accurate and consistent as a study moves from startup through enrollment, site operations, patient assessments, amendments, safety reporting, and closeout.
Sesen supports this multilingual content ecosystem as a coordinated program rather than a series of isolated translation requests. Our clinical trial translation services bring together specialized linguistic expertise, terminology management, translation memory, version control, quality assurance, multilingual formatting, and global program coordination.
Support for pharmaceutical and biotechnology sponsors, CROs, clinical operations teams, academic research organizations, healthcare institutions, and global study sites managing complex multilingual research programs.
Translation across clinical, regulatory, operational, safety, training, scientific, and patient-facing content—from technical protocols and investigator documentation to consent forms, questionnaires, and digital trial experiences.
Study-specific terminology controls help align language across protocols, ICFs, amendments, site documents, patient materials, clinical outcome assessments, safety content, and recurring study communications.
Professional linguists remain responsible for clinical meaning, contextual judgment, readability, and final quality. Translation technology, terminology intelligence, translation memory, and AI-assisted QA help strengthen consistency and identify potential issues at scale.
Managed multilingual workflows support regional and global clinical trials involving multiple languages, recurring amendments, changing study content, local language variants, reviewer coordination, and compressed timelines.
Global clinical research depends on multilingual information that can be understood and used correctly by very different audiences. Patients need clear information about participation. Investigators and sites need precise study instructions. Ethics committees and health authorities need complete documentation. Sponsors and CROs need consistent language across countries and versions.
ICFs, assent forms, privacy information, study instructions, and other participant-facing materials must preserve clinical meaning while remaining clear to the intended reader.
Investigators, coordinators, monitors, pharmacists, laboratory teams, and other site personnel rely on consistent study information across languages and locations.
Clinical trial translations may be reviewed by IRBs, ethics committees, health authorities, and local research stakeholders. Accuracy, completeness, document integrity, and version identification all matter.
Patient questionnaires, assessments, diaries, safety communications, and study instructions require careful attention to intended use, audience, terminology, and content type.
Protocol amendments, revised consent forms, safety updates, country-specific changes, and urgent communications require multilingual workflows that can move quickly without losing approved language.
Clinical trial translation does not begin and end with a single document. Multilingual content develops alongside the study, creating dependencies between protocols, patient materials, site documentation, clinical systems, safety communications, and final reporting.
Build a consistent multilingual foundation before sites and participants enter the study.
Prepare multilingual content for country-specific regulatory, institutional, and ethics review processes.
Communicate study participation clearly across languages and patient populations.
Give investigators and site teams consistent information for study setup and execution.
Support multilingual participant interaction, data collection, and clinical outcome measurement.
Keep study language synchronized when protocols, safety information, or participant requirements change.
Support multilingual reporting, transparency, publication, and post-study communication.
Sesen translates the clinical, regulatory, operational, patient-facing, safety, scientific, and digital content required throughout global clinical research. Related study materials can be managed within a coordinated terminology and quality framework instead of being treated as isolated deliverables.
Informed consent forms, assent forms, re-consent forms, privacy notices, HIPAA authorization forms, patient information sheets, study participation guides, participant instructions, patient education materials, and other consent-related communications.
Clinical trial protocols, protocol synopses, protocol amendments, eligibility and exclusion criteria, visit schedules, study procedures, endpoint descriptions, assessment instructions, statistical content, and related research materials.
Investigator brochures, site manuals, pharmacy manuals, laboratory manuals, monitoring plans, site activation materials, investigator meeting content, study instructions, site communications, and monitoring documentation.
Recruitment brochures, advertisements, digital outreach, screening materials, participant communications, appointment reminders, retention messages, patient newsletters, study education content, and multilingual engagement materials.
Standard operating procedures, Good Clinical Practice training, investigator training, site training, eLearning modules, onboarding content, clinical operations documentation, presentations, and job aids.
Clinical outcome assessments, patient-reported outcomes, ePROs, ClinROs, ObsROs, questionnaires, diaries, scales, and other clinical instruments, including linguistic validation workflows when required.
Adverse event narratives, serious adverse event documentation, safety letters, investigator safety updates, SUSAR-related communications, DSUR-related materials, risk information, and other pharmacovigilance documentation.
Clinical study reports, trial result summaries, plain-language summaries, appendices, clinical narratives, tables, listings, figures, statistical content, publications, manuscripts, abstracts, and disclosure-related materials.
eConsent, eCOA, ePRO, patient portals, clinical trial applications, decentralized trial platforms, clinical software, digital health instructions, device interfaces, notifications, help content, and software strings.
Some clinical content requires workflows that go beyond conventional document translation. Sesen provides dedicated solutions for high-value study content, validation requirements, patient communication, safety reporting, and digital trial environments.
Patient-appropriate ICF, assent, re-consent, privacy, and consent-related documentation.
Protocols, investigator brochures, study manuals, clinical reports, site documentation, and core research materials.
Structured translation and validation workflows for COAs, PROs, questionnaires, and clinical instruments.
Patient outreach, recruitment, screening, education, engagement, and retention communications.
Good Clinical Practice content, investigator and site training, SOPs, eLearning, and study onboarding.
eConsent, eCOA, ePRO, patient apps, portals, study platforms, and decentralized trial experiences.
Adverse-event content, safety communications, investigator updates, and global pharmacovigilance workflows.
Sesen adapts clinical trial translation workflows to the organization, study model, content risk, target markets, and operational requirements.
Support global clinical development from study startup through reporting, including protocols, informed consent, regulatory and ethics materials, patient content, amendments, safety communications, clinical reports, and ongoing study documentation.
Scalable workflows for multi-study and multi-country programs, including site startup, recruitment, patient communication, recurring amendments, investigator materials, urgent requests, and ongoing study operations.
Translation for device clinical investigations, usability studies, clinical evaluation materials, patient documentation, software interfaces, digital health tools, eCOA/ePRO environments, and study instructions.
Support for investigator-initiated trials, institutional research, study protocols, informed consent, participant communication, research questionnaires, training, publications, and multilingual community engagement.
Clinical trial translation quality depends on understanding what a document is for, who will use it, what terminology has already been approved, and how the content relates to other study materials. Sesen applies a managed workflow that can be aligned with document type, intended use, patient impact, regulatory context, and project requirements.
Review document type, intended audience and use, source quality, target languages, timeline, formatting environment, existing references, version status, and relevant clinical or patient-facing considerations.
Align approved terminology, sponsor glossaries, translation memories, previous translations, protocols, style guides, product or device terminology, and country-specific instructions.
Qualified native-language linguists with relevant clinical, medical, regulatory, safety, or patient communication expertise translate using approved project references.
A separate reviewer evaluates accuracy, completeness, terminology, meaning, readability, consistency, and suitability for the intended clinical context.
Automated and AI-assisted checks help identify potential issues involving terminology, numbers and units, omissions, inconsistencies, repeated content, tags, placeholders, punctuation, and formatting.
Final review confirms completeness, file integrity, version alignment, formatting, resolved queries, and delivery readiness. Human professionals retain final quality responsibility.
Artificial intelligence can make multilingual clinical workflows faster and more systematic, but clinical trial content requires a risk-aware approach. Sesen uses AI and language technology where they add measurable workflow value while keeping professional linguists responsible for clinical meaning and final quality.
Explore Clinical Trial AI WorkflowsFor appropriate content types and workflows, SesenGPT can support draft translation using domain-specific language context, approved terminology, reference materials, and existing linguistic assets.
Previously approved translations can be reused across protocols, amendments, site materials, training, and recurring study communications to support consistency and efficiency.
AI and automated QA can surface terminology mismatches, inconsistencies, numerical issues, missing content, and other anomalies for professional review.
Qualified life sciences linguists review clinical translations for contextual accuracy, medical meaning, terminology, readability, and audience appropriateness.
Human quality control remains the final checkpoint for regulated, patient-facing, clinical, and submission-related content.
A clinical trial is a moving body of information. Protocols are amended. Consent forms change. Safety language evolves. New countries and sites are added. Without centralized multilingual controls, small changes can create discrepancies across languages, documents, and study teams.
Sesen combines terminology governance, translation memory, version-aware project management, and structured review to help maintain linguistic continuity throughout the study lifecycle.
Clinical research content does not speak to one reader. Effective clinical trial translation preserves the underlying meaning while respecting how each audience uses the information.
Clinical trial applications, protocols, amendments, safety information, clinical study reports, registry content, results, and other regulatory-facing documentation.
Consent forms, assent forms, patient information, recruitment materials, protocol summaries, privacy content, and other review materials.
Study manuals, training, protocols, pharmacy and laboratory instructions, site communications, safety updates, and operational content.
Informed consent, recruitment materials, questionnaires, patient instructions, diaries, digital interfaces, and other participant-facing content.
Clinical research increasingly extends beyond traditional site-based visits. Remote interactions, eConsent, eCOA/ePRO, mobile applications, connected technologies, telehealth, wearables, patient portals, and decentralized trial elements create more multilingual touchpoints between participants and study teams.
Sesen helps life sciences organizations localize the language layer of these modern trial environments while keeping human review, terminology control, and patient comprehension central to the workflow.
Explore Decentralized Clinical Trial TranslationElectronic consent experiences, participant instructions, privacy content, supporting information, interface text, and updated consent versions.
Electronic outcome assessments and patient-reported outcomes, including interface strings, instructions, questionnaires, notifications, and validation-related workflows.
Trial applications, participant dashboards, appointment content, help information, educational materials, reminders, messages, and other patient-facing digital experiences.
Materials used for telehealth, home-based participation, remote monitoring, direct-to-patient activities, and other decentralized clinical trial elements.
User-facing content associated with software, connected devices, wearables, sensors, and other digital technologies incorporated into clinical studies.
Digital recruitment, enrollment, education, reminders, retention, and ongoing participant communication within a consistent multilingual experience.
Centralized multilingual delivery for regional and global studies.
Global trials require more than adding languages to a document list. They require coordination across countries, local language variants, study sites, translators, reviewers, timelines, versions, and changing source content.
U.S., Canadian, and regional study requirements.
EU, EEA, UK, Swiss, and other European markets.
Spanish and Portuguese clinical translation with regional language support.
Major research markets across East Asia, Southeast Asia, South Asia, Australia, and surrounding regions.
Arabic, Hebrew, Turkish, and additional regional language support.
Selected national, regional, and local language requirements.
Representative languages: Spanish · French · German · Italian · Portuguese · Dutch · Polish · Czech · Hungarian · Romanian · Greek · Turkish · Arabic · Hebrew · Chinese · Japanese · Korean · Thai · Vietnamese · Hindi and more.
A clinically accurate translation still needs to function as a usable document. Clinical trial materials frequently contain complex tables, tracked changes, signature fields, footnotes, forms, graphics, appendices, controlled templates, and structured content.
Clinical research organizations entrust language partners with confidential study information, investigational product details, patient-related content, unpublished results, regulatory documentation, and commercially sensitive materials.
ISO 17100 translation-services quality requirements, ISO 9001 quality management processes, and ISO 13485 quality management expertise relevant to medical device and regulated life sciences environments.
Clinical content is assigned to professional native linguists with appropriate clinical, medical, regulatory, safety, scientific, or patient-facing experience. Independent review and final QC add additional checkpoints.
AWS-hosted infrastructure, controlled access, role-based permissions, NDA support, and documented project workflows support confidential clinical translation and customer-specific handling requirements.
Clinical research translation rarely follows a perfectly static plan. Sesen's workflows are designed around the practical challenges that sponsors, CROs, and study teams encounter as trials move across countries and phases.
Translation memory, version comparison, and terminology controls help update changed content while preserving approved language.
ICFs, questionnaires, instructions, and recruitment materials need language appropriate to the intended participant population.
Centralized coordination helps align language-country combinations, local reviewers, and overlapping timelines.
Study-specific terminology resources help maintain consistency across medical, scientific, statistical, operational, regulatory, and safety content.
Forms, tables, tracked changes, eCOA interfaces, study systems, and formatted files require linguistic and technical quality assurance.
Scalable linguistic teams and controlled review workflows help support safety updates, amendments, and site-critical communications.
Clinical translation requires a partner that understands both language and the operating realities of global life sciences programs.
Clinical trials, regulatory affairs, pharmacovigilance, medical devices, healthcare, digital health, medical and scientific content.
Appropriate native-language specialists matched to the therapeutic area, content type, audience, and workflow requirements.
ISO 17100, ISO 9001, and ISO 13485 support a structured quality environment for regulated multilingual content.
Study glossaries, sponsor-approved terminology, translation memories, reference materials, and version-aware workflows.
Clinical research programs across 150+ languages, from individual documents to ongoing multi-country translation programs.
AWS-hosted infrastructure, controlled file access, confidentiality practices, and project-level controls for sensitive clinical content.
Explore practical Sesen guidance for clinical, regulatory, and localization teams managing informed consent, patient comprehension, linguistic validation, ethics review, AI-assisted translation, digital trials, and multilingual quality.
Patient readability, study terminology, version management, and formatted delivery for multilingual ICFs.
Explore ResourceUnderstand where back translation fits, how linguistic validation differs from standard translation, and how methodology should reflect intended use.
Explore ResourceA risk-managed approach to terminology control, human validation, review checkpoints, and appropriate AI workflow selection.
Explore ResourceAnswers to common questions from sponsors, CROs, and study teams planning multilingual clinical trial translation programs.
Clinical trial translation is the translation and localization of documents, patient materials, forms, site communications, regulatory content, safety information, clinical outcome assessments, training, reports, and digital tools used in clinical research. Unlike general translation, it often requires specialized medical and regulatory terminology, study-level consistency, version control, appropriate review workflows, and an understanding of how different documents are used by patients, investigators, ethics committees, regulators, and clinical operations teams.
Sesen translates informed consent forms, protocols and amendments, investigator brochures, site manuals, pharmacy and laboratory manuals, patient recruitment materials, GCP training, clinical outcome assessments, PROs and ePROs, questionnaires, safety communications, adverse-event content, clinical study reports, plain-language summaries, eConsent, eCOA, patient portals, and digital trial content. Related documents can be managed within shared terminology and translation-memory resources to help maintain study consistency.
Yes. Informed consent forms communicate information about study participation, procedures, potential risks and benefits, participant responsibilities, privacy, and rights. Translation needs to preserve clinical meaning while remaining understandable to the intended participant population. ICF projects may also require careful formatting, terminology control, local language variants, ethics committee considerations, version management, and coordinated updates.
Yes. Sesen can support protocol amendments, revised informed consent forms, safety updates, IRB or ethics committee responses, site communications, and other time-sensitive clinical content. Translation memory, approved terminology, version comparison, and established linguistic teams can help accelerate updates while maintaining consistency with previously approved study language.
Yes, within a controlled, human-led workflow rather than treating every clinical document the same. Depending on content type and project requirements, AI may support draft translation, terminology application, consistency analysis, repetitive content reuse, and quality assurance. Qualified life sciences linguists remain responsible for clinical meaning, contextual judgment, readability, and final quality.
Yes. Sesen supports multilingual clinical trial programs across 150+ languages, including regional and global studies requiring many target languages at the same time. Larger programs can centralize terminology, translation memory, project instructions, reviewer feedback, and recurring updates so individual markets remain aligned with the broader study.
Yes. Sesen provides multilingual formatting and desktop publishing for Word, PDF, Excel, PowerPoint, InDesign, XML, structured content, forms, tables, training materials, and other clinical file environments. Formatting can include tables, tracked changes, headers and footers, signature areas, appendices, text expansion, graphics, and other layout requirements.
Yes. Sesen supports translation and linguistic validation-related workflows for COAs, PROs, ePROs, ClinROs, ObsROs, diaries, questionnaires, scales, and other patient instruments. Where formal linguistic validation is required, workflows can include forward translation, reconciliation, back translation, harmonization, cognitive debriefing support, and documentation.
Yes. Sesen supports pharmaceutical and biotechnology sponsors, CROs, medical device companies, digital health organizations, academic research institutions, healthcare organizations, and other teams conducting multilingual clinical research. Engagements can range from individual documents to ongoing multi-study and multi-country translation programs.
Where available, provide final or near-final source files together with relevant reference material such as approved terminology, previous translations, study protocols, current document versions, sponsor glossaries, style guides, translation memories, country and language requirements, formatting expectations, reviewer instructions, and required delivery dates. Identifying the relationship between new files and previously translated content can improve both consistency and efficiency.
From study startup and informed consent through site operations, patient assessments, protocol amendments, safety communications, digital trial experiences, and final reporting, Sesen helps clinical research teams keep multilingual content accurate, consistent, controlled, and ready for its intended audience.
Whether you are planning a new multi-country study, expanding into additional markets, managing recurring amendments, or looking for a more scalable clinical translation partner, Team Sesen can help you build the right workflow for your program.
